Bilirubin Metabolism & Jaundice

From red cell to yellow pigment

Every red blood cell lives about 120 days. When it ages, becomes damaged, or is otherwise marked for removal, macrophages of the reticuloendothelial system — concentrated in the spleen, liver, and bone marrow — engulf it and tear apart its hemoglobin. Globin chains are recycled into amino acids, iron is salvaged and returned to the marrow on transferrin, and the porphyrin ring at the center of heme is dismantled to make bilirubin. An adult turns over enough hemoglobin to generate roughly 250 to 400 mg of bilirubin per day, around 4 mg per kilogram. About 80 to 85 percent of that comes from senescent red cells; the rest comes from other heme proteins like myoglobin and the cytochromes, plus a small contribution from red cells that die prematurely in the marrow (ineffective erythropoiesis).

The first committed step is performed by heme oxygenase, which cracks open the heme ring and releases three products: carbon monoxide (the body's only meaningful endogenous source of CO, used as a marker of hemolysis on exhaled-breath testing), ferrous iron, and the green pigment biliverdin. A second enzyme, biliverdin reductase, immediately reduces green biliverdin to yellow-orange unconjugated bilirubin. This color sequence is visible to anyone who has watched a bruise change from purple to green to yellow as trapped heme is processed in the skin.

Albumin: a taxi for an insoluble passenger

Unconjugated bilirubin has a problem — it is essentially insoluble in water. It cannot simply dissolve in plasma and float to the liver. Instead, each molecule binds tightly and reversibly to albumin, which acts as a carrier and keeps the free, diffusible fraction extremely low. This matters clinically: drugs that displace bilirubin from albumin (sulfonamides, ceftriaxone in neonates) raise the free fraction and, in a newborn, can let unconjugated bilirubin cross the blood-brain barrier and deposit in the basal ganglia. Because unconjugated bilirubin is albumin-bound and lipid-soluble, it is never filtered by the kidney and never appears in urine — a key diagnostic point.

At the hepatocyte, bilirubin dissociates from albumin and is taken up across the sinusoidal membrane (with help from transporters such as OATP1B1). Inside the cell it binds ligandin (glutathione-S-transferase) to keep it from leaking back out, then is delivered to the smooth endoplasmic reticulum for the central event of the whole pathway: conjugation.

Conjugation: making bilirubin water-soluble

The enzyme UDP-glucuronosyltransferase 1A1 (UGT1A1) attaches one and then a second molecule of glucuronic acid to bilirubin, producing bilirubin monoglucuronide and then diglucuronide. This conjugated (direct) bilirubin is now water-soluble. Solubility is the entire point: only the conjugated form can be actively pumped across the canalicular membrane into bile by the transporter MRP2/ABCC2. The handoff is one-directional under normal conditions, which is why a healthy person's blood contains almost entirely unconjugated bilirubin (direct fraction under about 0.3 mg/dL).

UGT1A1 is the bottleneck of the system and the site of several classic diseases. Reduce its activity modestly and you get Gilbert syndrome, a benign condition in 5 to 10 percent of people in which mild unconjugated jaundice flares during fasting, illness, or stress. Knock the enzyme out almost entirely and you get Crigler-Najjar syndrome — type II is partial and responds to phenobarbital, while type I is near-complete absence and is lethal without phototherapy and liver transplantation.

The gut, the kidney, and the colors of waste

Once conjugated bilirubin reaches the intestine in bile, colonic bacteria deconjugate and reduce it to a family of compounds collectively called urobilinogen. Most urobilinogen is further oxidized to stercobilin, the brown pigment that gives stool its color. A fraction is reabsorbed into the portal blood (the enterohepatic circulation); most of that is re-excreted by the liver, but a small amount reaches the systemic circulation, is filtered by the kidney, and is oxidized to urobilin, the pigment that makes urine yellow. These downstream colors are diagnostic shorthand: lose the pigment delivery to the gut and stools turn pale (clay-colored); back conjugated bilirubin up into the blood and the kidneys dump it into urine, turning it dark.

Jaundice: when the pigment backs up

Jaundice (icterus) is the visible yellowing of skin, mucous membranes, and especially the elastin-rich sclera when total bilirubin rises above roughly 2 to 3 mg/dL — two to three times the normal upper limit. Clinicians classify jaundice by where in the pathway the problem sits, because that determines whether the unconjugated or the conjugated fraction is elevated and what the work-up should be.

• Pre-hepatic (hemolytic). Excess red cell destruction floods the liver with more bilirubin than it can conjugate. The unconjugated fraction rises, urine bilirubin is absent (it is not water-soluble), and urine urobilinogen is high. Causes include sickle cell disease, G6PD deficiency, hereditary spherocytosis, and autoimmune hemolysis.
• Hepatic (hepatocellular). The liver cells themselves are sick, impairing uptake, conjugation, and excretion. Both fractions usually rise. Causes include viral hepatitis, alcoholic and non-alcoholic steatohepatitis, drug injury, and cirrhosis.
• Post-hepatic (obstructive / cholestatic). Conjugated bilirubin is made normally but cannot exit because the bile duct is blocked — by a gallstone, a stricture, or pancreatic-head cancer. The conjugated fraction rises, urine turns dark, stools turn pale, and bile salts in the skin cause itching.

Pre-hepatic vs post-hepatic jaundice

The single most useful bedside distinction is whether the problem is upstream of the liver (too much pigment) or downstream (the exit is blocked). The pattern of urine and stool color, plus the conjugated fraction, separates them cleanly.

Feature	Pre-hepatic (hemolytic)	Post-hepatic (obstructive)
Predominant bilirubin	Unconjugated (indirect)	Conjugated (direct)
Underlying problem	Overproduction from hemolysis	Blocked bile flow (stone, tumor, stricture)
Urine bilirubin	Absent (not water-soluble)	Present — urine is dark
Urine urobilinogen	Increased	Decreased or absent
Stool color	Normal to dark	Pale / clay-colored
Itching (pruritus)	Absent	Common (retained bile salts)
Liver enzymes	Usually normal; LDH and reticulocytes up	Alkaline phosphatase and GGT markedly up

Neonatal jaundice and kernicterus

Nearly two-thirds of healthy newborns develop visible jaundice in the first week of life, and understanding why follows directly from the pathway. Newborns carry a high red cell mass made of shorter-lived fetal cells, so they produce bilirubin two to three times faster per kilogram than adults. Their UGT1A1 enzyme is still immature, and intestinal beta-glucuronidase deconjugates bilirubin so that it is reabsorbed through an exaggerated enterohepatic circulation. The result is physiologic jaundice that peaks around day 3 to 5 and resolves on its own.

The danger is that unconjugated bilirubin is neurotoxic. If levels climb high enough — classically above 20 to 25 mg/dL — the free pigment crosses the immature blood-brain barrier and stains and damages the basal ganglia, causing acute bilirubin encephalopathy and, if untreated, permanent kernicterus (choreoathetoid cerebral palsy, hearing loss, and gaze palsy). Treatment is elegant physics: blue light at about 460 nm (phototherapy) isomerizes skin bilirubin into water-soluble lumirubin that can be excreted without conjugation, and exchange transfusion is reserved for the most extreme levels. Jaundice that appears in the first 24 hours, or that is predominantly conjugated, is never physiologic and demands urgent work-up.

Why this pathway matters in the clinic

• The first lab split. Fractionating total bilirubin into direct and indirect immediately narrows the differential — hemolysis and Gilbert versus liver disease versus obstruction.
• Tumor marker by accident. Painless jaundice with a palpable, non-tender gallbladder (Courvoisier sign) raises concern for pancreatic or biliary malignancy rather than gallstones.
• Drug metabolism. UGT1A1 also conjugates the chemotherapy metabolite SN-38; patients with Gilbert-type genotypes can suffer severe toxicity from irinotecan, and the same enzyme handles atazanavir and other drugs.
• Transfusion and resorption. A large bruise or hematoma, or breakdown of transfused red cells, can transiently raise unconjugated bilirubin even with a perfectly normal liver.
• An antioxidant in disguise. Mildly elevated bilirubin, as in Gilbert syndrome, is a potent scavenger of free radicals and is epidemiologically associated with lower rates of cardiovascular disease — a reminder that this "waste" pigment is not entirely waste.

This article is educational and is not medical advice. New or worsening jaundice, pale stools, or dark urine should be evaluated by a clinician.